Novel Fusion Gene PTPRC-Cyrib As a Drug Resistance Mechanism in T-ALL
Xindi Li, Le Yin, Zhihua Wang, Yue Sheng, Zhao Cheng, Hongling Peng
Central South University Second Xiangya Hospital of Central South University Xiangya Hospital Central South University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
OBJECTIVE To investigate the mechanisms of resistance conferred by the novel fusion gene PTPRC-CYRIB in T-cell acute lymphoblastic leukemia (T-ALL). METHODS Using next generation sequencing, we identified the novel fusion gene PTPRC-CYRIB in the bone marrow of a primary drug-resistant T-ALL patient, subsequently confirmed its presence by Sanger sequencing. Molecular cloning techniques were employed to construct a plasmid overexpressing the PTPRC-CYRIB gene. Stable overexpression of PTPRC-CYRIB in T-ALL cell lines was achieved via lentiviral transduction. The T-ALL cell line overexpressing PTPRC-CYRIB was designated as the overexpression (OE) group, while the control group (NC) consisted of cells transduced with empty vector. Polymerase chain reaction (PCR) and western blotting (WB) confirmed PTPRC-CYRIB gene expression in transduced cells. Growth curves were plotted to assess proliferation rates, colony formation assays were conducted to evaluate clonogenic potential, and cell counting Kit-8 (CCK8) assays were performed following treatment with Vincristine, Idarubicin, Cyclophosphamide, and Prednisone to determine drug resistance in the OE group compared to the NC group. RESULTS We successfully constructed stable T-ALL cell lines overexpressing PTPRC-CYRIB. PCR and WB analysis confirmed PTPRC-CYRIB overexpression in the OE group compared to the NC group. Growth curve analysis revealed significantly increased proliferation rates in the OE group. Colony formation assays demonstrated enhanced clonogenic potential in OE cells. Following drug intervention, CCK8 assays indicated significantly reduced inhibitory effects of Vincristine, Idarubicin, Cyclophosphamide, and Prednisone on proliferation in the OE group compared to the NC group, with statistical significance (P < 0.05). CONCLUSION Overexpression of the fusion gene PTPRC-CYRIB in T-ALL may contribute to the development of drug resistance.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Acute Lymphoblastic Leukemia research
Protein Tyrosine Phosphatases · Acute Myeloid Leukemia Research